Pamela Bachanas
Overview
Explore the profile of Pamela Bachanas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
546
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chun H, Milligan K, Adetinuke Boyd M, Abutu A, Bachanas P, Dirlikov E
AIDS
. 2023 Jul;
37(13):2081-2085.
PMID: 37503650
Background: Virologic suppression has been defined using a HIV viral load of less than 1000 copies/ml. Low-level viremia (51-999 copies/ml) is associated with an increased risk of virologic failure and...
2.
Larmarange J, Bachanas P, Skalland T, Balzer L, Iwuji C, Floyd S, et al.
PLOS Glob Public Health
. 2023 Jul;
3(7):e0002157.
PMID: 37450436
Universal HIV testing and treatment (UTT) strategies aim to optimize population-level benefits of antiretroviral treatment. Between 2012 and 2018, four large community randomized trials were conducted in eastern and southern...
3.
4.
Bhebhe L, Moyo S, Gaseitsiwe S, Pretorius-Holme M, Yankinda E, Manyake K, et al.
BMC Infect Dis
. 2022 Aug;
22(1):710.
PMID: 36031617
Background: HIV-1 is endemic in Botswana. The country's primary challenge is identifying people living with HIV who are unaware of their status. We evaluated factors associated with undiagnosed HIV infection...
5.
Ussery F, Bachanas P, Alwano M, Lebelonyane R, Block L, Wirth K, et al.
J Acquir Immune Defic Syndr
. 2022 May;
91(1):9-16.
PMID: 35537094
Background And Setting: The Botswana Combination Prevention Project demonstrated a 30% reduction in community HIV incidence through expanded HIV testing, enhanced linkage to care, and universal antiretroviral treatment and exceeded...
6.
Resch S, Foote J, Wirth K, Lasry A, Scott J, Moore J, et al.
J Acquir Immune Defic Syndr
. 2022 Apr;
90(4):399-407.
PMID: 35420554
Background: The Botswana Combination Prevention Project tested the impact of combination prevention (CP) on HIV incidence in a community-randomized trial. Each trial arm had ∼55,000 people, 26% HIV prevalence, and...
7.
Lickness J, Bachanas P, Tohme R, Russell A, Craig A, Hakim A
Pan Afr Med J
. 2022 Mar;
40:254.
PMID: 35251448
The coronavirus disease 2019 (COVID-19) pandemic has substantially impacted health systems globally. To highlight potential opportunities to improve health service delivery in low- and middle-income countries, we describe lessons learned...
8.
Jahun I, Said I, El-Imam I, Ehoche A, Dalhatu I, Yakubu A, et al.
PLoS One
. 2021 Sep;
16(9):e0257476.
PMID: 34543306
Background: Ineffective linkage to care (LTC) is a known challenge for community HIV testing. To overcome this challenge, a robust linkage to care strategy was adopted by the 2018 Nigeria...
9.
Boyd A, Jahun I, Dirlikov E, Greby S, Odafe S, Abdulkadir A, et al.
AIDS Res Ther
. 2021 Sep;
18(1):62.
PMID: 34538268
Background: To accelerate progress toward the UNAIDS 90-90-90 targets, US Centers for Disease Control and Prevention Nigeria country office (CDC Nigeria) initiated an Antiretroviral Treatment (ART) Surge in 2019 to...
10.
Jahun I, Dirlikov E, Odafe S, Yakubu A, Boyd A, Bachanas P, et al.
HIV AIDS (Auckl)
. 2021 Sep;
13:839-850.
PMID: 34471388
Purpose: The 2018 Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) showed Nigeria's progress toward the UNAIDS 90-90-90 targets: 47% of HIV-positive individuals knew their status; of these, 96% were receiving...